Southwest District Health will no longer offer the COVID-19 vaccine to residents who want to pay for it.

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

Many people don’t know they’re eligible. | Moderna has identified a fundamental barrier to vaccination: many people don’t ...

The CDC recommends that immunocompromised people and those age 65 and older should get a second dose of the 2024-2025 COVID ...

Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...

Immunocompromised adults or those who are older than 65 should get a second dose of the latest COVID-19 vaccine, the Centers ...

Urge your representatives in Congress to support its programs to increase access to vaccines around the world.

Immunocompromised people and those who are over 65 years of age or older should get a second dose of this year’s COVID-19 ...

Moderna shares rebound after six days of losses. Analysts mixed on stock with Strong Sell rating but potential for future growth.

A vaccine to protect against the winter vomiting bug norovirus is set for a year-long trial by the UK’s National Health Service (NHS) after early results showed it creates a “strong immune response.” ...

Today, CDC's Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo allowing Novavax monovalent COVID-19 boosters for adults.